Studies conducted on in vivo models of endometriosis confirmed both the proapoptotic and anti-invasive role of resveratrol and its inhibitory effect on angiogenesis, as evidenced by a decrease in the expression of various pro-inflammatory, pro-invasive, and pro-angiogenic factors [94,95,96], including IL-6/8, VEGF, and monocyte chemoattractant protein 1 (MCP-1). Here, CCL2 is linked to endometriosis.